Abstract
Despite advances in antimicrobial therapy and supportive measures, mortality in patients with severe community- acquired pneumonia admitted to the intensive care unit remains high, especially in case of development of sepsis with its complications. Systemic inflammation is a major feature of severe community-acquired pneumonia worsening to sepsis. This uncontrolled inflammation is sustained by genetic mechanisms throughout an exaggerated activation of the nuclear factor NF-B. Glucocorticoids inhibit the activity of NF-κB intracellularly. On the base of this concept, the data emerged from scientific literature and from a recent randomized trial on patients with severe community acquired pneumonia support the hypothesis that prolonged infusion of low doses of hydrocortisone may accelerate the resolution of the pneumonia and prevent the development of severe complications due to sepsis. Moreover, this therapeutic approach seems to be associated with a significant reduction in duration of mechanical ventilation, length of hospital stay and long-term mortality.
Keywords: Glucocorticoids, community-acquired pneumonia, severe pneumonia, inflammatory response
Current Respiratory Medicine Reviews
Title: Prolonged Physiologic Doses of Corticosteroids for the Treatment of Severe Community Acquired Pneumonia
Volume: 5 Issue: 2
Author(s): Pietro Geri, Roberto Trevisan, Rossella Cifaldi, Marco Biolo, Chiara Torregiani, Metka Kodric, Fabio Giuseppe Vassallo and Marco Confalonieri
Affiliation:
Keywords: Glucocorticoids, community-acquired pneumonia, severe pneumonia, inflammatory response
Abstract: Despite advances in antimicrobial therapy and supportive measures, mortality in patients with severe community- acquired pneumonia admitted to the intensive care unit remains high, especially in case of development of sepsis with its complications. Systemic inflammation is a major feature of severe community-acquired pneumonia worsening to sepsis. This uncontrolled inflammation is sustained by genetic mechanisms throughout an exaggerated activation of the nuclear factor NF-B. Glucocorticoids inhibit the activity of NF-κB intracellularly. On the base of this concept, the data emerged from scientific literature and from a recent randomized trial on patients with severe community acquired pneumonia support the hypothesis that prolonged infusion of low doses of hydrocortisone may accelerate the resolution of the pneumonia and prevent the development of severe complications due to sepsis. Moreover, this therapeutic approach seems to be associated with a significant reduction in duration of mechanical ventilation, length of hospital stay and long-term mortality.
Export Options
About this article
Cite this article as:
Geri Pietro, Trevisan Roberto, Cifaldi Rossella, Biolo Marco, Torregiani Chiara, Kodric Metka, Vassallo Giuseppe Fabio and Confalonieri Marco, Prolonged Physiologic Doses of Corticosteroids for the Treatment of Severe Community Acquired Pneumonia, Current Respiratory Medicine Reviews 2009; 5 (2) . https://dx.doi.org/10.2174/157339809788189969
DOI https://dx.doi.org/10.2174/157339809788189969 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Hellp Syndrome: A Review
Current Women`s Health Reviews Diagnosis and Management of Hypertensive Emergencies Complicating Pregnancy
Current Women`s Health Reviews Cyclin-Dependent Kinase Inhibition by Flavoalkaloids
Mini-Reviews in Medicinal Chemistry Protease-Activated Receptor-2 Antagonists and Agonists
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials
Current Drug Targets Developments in Selective Small Molecule ATP-Targeting the Serine/Threonine Kinase Akt/PKB
Mini-Reviews in Medicinal Chemistry Catheter Ablation of Lone Atrial Fibrillation
Current Pharmaceutical Design Chemical Constituents and Biological Significance of the Genus Ilex (Aquifoliaceae)
The Natural Products Journal An Update on Clinical Drug Interactions with the Herbal Antidepressant St. Johns wort
Current Drug Metabolism Efficacy and Safety of Nonopioid Analgesics in Perioperative Pain Control
Current Drug Safety Pharmacotherapy in Type 2 Diabetes: A Functional Schema for Drug Classification
Current Diabetes Reviews Amaranth: A Pseudo-Cereal with Nutraceutical Properties
Current Nutrition & Food Science Cardiovascular Effects of EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibodies
Cardiovascular & Hematological Agents in Medicinal Chemistry Immunological Impact of Whey Protein on Peripheral Blood Mononuclear Cells of Patients with Chronic Liver Disease
Current Nutrition & Food Science Editorial (Thematic Issue: Stereoselective Synthesis and Applications of Compounds with N-O Bonds)
Current Organic Synthesis Nicotinic Acetylcholine Receptor Agonists: A Potential New Class of Analgesics
Current Topics in Medicinal Chemistry Nitroxides as Cancer Imaging Agents
Anti-Cancer Agents in Medicinal Chemistry The Key Role of Medullary 5-HT3 Receptors in the Serotonin-Mediated Neural Control of Cardiovascular Function
Current Neuropharmacology Inflammatory Caspases: Targets for Novel Therapies
Current Pharmaceutical Design The Epidemiology of Sepsis
Current Pharmaceutical Design